Author [ Title(Asc)] Type Year
Filters: First Letter Of Title is V  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Huang Y, Yuan L, Li T, Wang A, Li Z, Pang D, Wang B, Ouyang H. Valproic Acid Improves Porcine Parthenogenetic Embryo Development Through Transient Remodeling of Histone Modifiers. Cell Physiol Biochem. 2015;37(4):1463-1473.
Ghosouri S, Bakhtiari M, Mitra S, Ghasemi N. Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis. Int J Dev Biol. 2023;67(3):101-108.
Nevo N, Lecourt S, Bieche I, Kucia M, Cras A, Blandinières A, Vacher S, Gendron N, Guérin CL, Ratajczak MZ, et al. Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process. Stem Cell Rev Rep. 2020.
Kuhl CK, Alparslan Y, Schmoee J, Sequeira B, Keulers A, Brümmendorf TH, Keil S. Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study. Radiology. 2018:180648.
Oudega M, Hao P, Shang J, Haggerty AE, Wang Z, Sun J, Liebl DJ, Shi Y, Cheng L, Duan H, et al. Validation study of neurotrophin-3-releasing chitosan facilitation of neural tissue generation in the severely injured adult rat spinal cord. Exp Neurol. 2018.
You CZ, Xu H, Zhao FS, Dou J. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells. Bull Exp Biol Med. 2024.
Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, et al. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. Blood. 2014.
Salaroglio IChiara, Abate C, Rolando B, Battaglia L, Gazzano E, Colombino E, Costamagna C, Annovazzi L, Mellai M, Berardi F, et al. Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells. Mol Pharm. 2019.
Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EMaria, Versluis J, Schroeder T, Blau IWolfgang, et al. Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2023.
Lee W-H, Tsai M-T, Tsai C-H, Tien F-M, Lo M-Y, Tseng M-H, Kuo Y-Y, Liu M-C, Yang Y-T, Chen J-C, et al. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood Cancer J. 2023;13(1):120.
Zhang X, Gale RPeter, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, et al. Validation of the imatinib-therapy failure model. Leukemia. 2023.
Madadi-Sanjani O, Kuebler JF, Brendel J, Costanzo S, Granström AL, Aydin E, Loukogeorgakis S, Lacher M, Wiesner S, Domenghino A, et al. Validation of the Clavien-Madadi Classification for Unexpected Events in Pediatric Surgery: A Collaborative ERNICA Project. J Pediatr Surg. 2024.
Apolito V, Arrigo G, Vasseur L, Olivi M, Perrone S, Giai V, Secreto C, Di Biase F, De Simone MCarla, Copia C, et al. Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax. Br J Haematol. 2023.
Lysák D, Holubová M, Bergerová T, Vávrová M, Cangemi GCristina, Ciccocioppo R, Kruzliak P, Jindra P. Validation of shortened 2-day sterility testing of mesenchymal stem cell-based therapeutic preparation on an automated culture system. Cell Tissue Bank. 2015.
Gaur N, Ortega F, Verkerk AO, Mengarelli I, Krogh-Madsen T, Christini DJ, Coronel R, Vigmond EJ. Validation of quantitative measure of repolarization reserve as a novel marker of drug induced proarrhythmia. J Mol Cell Cardiol. 2020.
Korell F, DeFilipp Z, Schreck N, Luft T. Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation. Intensive Care Med. 2023.
Kakodkar P, Zhao Y, Pan H, Wu F, Pearce T, Webster D, Elemary M, Sabry W, Kwan L, Pelzer L, et al. Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation. Front Genet. 2023;14:1282947.
Mohanna A, Owaidah A, Albahrani A, Aldossary S, Almulhem N, Almohanna H. Validation of long-term handling and storage conditions for hematopoietic stem cell products for autologous transplants. J Med Life. 2023;16(4):515-519.
Cîmpean AMaria, Comşa Ş, Sturza A, Barb ACristina, Cosma AAlexandru, Fenesan MPasca, Ionescu C, Ile AMaria, Sarb S, Chis M. Validation of Human Bone Marrow-derived Mesenchymal Stem Cells and MCF-7 Breast Cancer Cells Co-culture Using a 3D Perfused Biomimetic Microfluidic Platform. Anticancer Res. 2024;44(4):1441-1453.
Bala M, Pratap K, Verma PKumar, Singh B, Padwad Y. Validation of ethnomedicinal potential of Tinospora cordifolia for anticancer and immunomodulatory activities and quantification of bioactive molecules by HPTLC. J Ethnopharmacol. 2015:JEPD1500646.
Mohamed S-A, Viknaswaran NLee, Doran J, Sanz-Nogués C, Ahmed K, Howard L, Tubassam M, O'Brien T, Walsh SRedmond. Validation of ERICVA Risk Score as a Predictor of One Year Amputation-Free Survival of Patients with Critical Limb Ischemia. Ann Vasc Surg. 2021.
Qi S, Li B, Yang T, Liu Y, Cao S, He X, Zhang P, Li L, Xu C. Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice. Int J Mol Sci. 2014;15(11):20004-20021.
Pinal-Fernandez I, Pak K, Casal-Dominguez M, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Validation of anti-Mi2 autoantibody testing by line blot. Autoimmun Rev. 2019:102425.
Gill EL, Gill CM, McEvoy C. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Ann Hematol. 2024.
Sandner S, Merz E-M, van den Hurk K, van Kraaij M, Mikkelsen C, Ullum H, Clement M. Validation of a standardized donor health questionnaire across substances of human origin. Vox Sang. 2020.